Cancer stem cells in colorectal cancer from pathogenesis to therapy: Controversies and perspectives

作者: Caterina Fanali , Donatella Lucchetti , Marisa Farina , Maddalena Corbi , Valerio Cufino

DOI: 10.3748/WJG.V20.I4.923

关键词:

摘要: Colorectal cancer remains one of the most common and lethal malignancies worldwide despite use various therapeutic strategies. A better understanding mechanisms responsible for tumor initiation progression is essential development novel, more powerful therapies. The traditional, so-called “stochastic model” development, which assumes that each cell tumorigenic, has been deeply challenged during past decade by identification stem cells (CSCs), a biologically distinct subset within bulk mass. This discovery led to hierarchical model tumorigenesis only CSCs have ability initiate growth, both at primary metastatic sites. implies elimination all fundamental eradicate tumors failure do so might be occurrence relapses and/or metastases frequently observed in clinical management colorectal patients. Identification isolation their role tumorigenetic process CSC-specific Several methods used this purpose many efforts focused on specific CSC-surface markers. review provides an overview proposed roles CSC human focusing important molecules identified as markers potential strategies CSC-targeted therapy.

参考文章(131)
Alessandro Sgambato, Maddalena Corbi, Maria Svelto, Emanuele Caredda, Achille Cittadini, New Insights into the CD133 (Prominin-1) Expression in Mouse and Human Colon Cancer Cells Advances in Experimental Medicine and Biology. ,vol. 777, pp. 145- 166 ,(2013) , 10.1007/978-1-4614-5894-4_10
Celia Chao, J Russ Carmical, Kirk L Ives, Thomas G Wood, Judith F Aronson, Guillermo A Gomez, Clarisse D Djukom, Mark R Hellmich, CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133− cells Laboratory Investigation. ,vol. 92, pp. 420- 436 ,(2012) , 10.1038/LABINVEST.2011.185
Sheri Miraglia, Wayne Godfrey, Amy H. Yin, Kristin Atkins, Roger Warnke, Jeannine T. Holden, Robert A. Bray, Edmund K. Waller, David W. Buck, A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood. ,vol. 90, pp. 5013- 5021 ,(1997) , 10.1182/BLOOD.V90.12.5013
Wolf-Gerolf Thies, Andrea Nestl, Peter Herrlich, Oliver D. Von Stein, Martin Hofmann, Kurt Zatloukal, Jonathan P. Sleeman, Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Research. ,vol. 61, pp. 1569- 1577 ,(2001)
Richard O. Hynes, Integrins: Bidirectional, Allosteric Signaling Machines Cell. ,vol. 110, pp. 673- 687 ,(2002) , 10.1016/S0092-8674(02)00971-6
P Went, M Vasei, L Bubendorf, L Terracciano, L Tornillo, U Riede, J Kononen, R Simon, G Sauter, P A Baeuerle, Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. British Journal of Cancer. ,vol. 94, pp. 128- 135 ,(2006) , 10.1038/SJ.BJC.6602924
Jyoti Nautiyal, Shailender S Kanwar, Yingjie Yu, Adhip P N Majumdar, Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells Journal of Molecular Signaling. ,vol. 6, pp. 7- 7 ,(2011) , 10.1186/1750-2187-6-7
Jamie N. Anastas, Randall T. Moon, WNT signalling pathways as therapeutic targets in cancer Nature Reviews Cancer. ,vol. 13, pp. 11- 26 ,(2013) , 10.1038/NRC3419
Jian-Ming Feng, Ze-Hong Miao, Yi Jiang, Yi Chen, Jia-Xin Li, Lin-Jiang Tong, Jin Zhang, Yi-Ran Huang, Jian Ding, Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line. Cancer Biology & Therapy. ,vol. 13, pp. 1396- 1406 ,(2012) , 10.4161/CBT.22000
Ranju Ralhan, Helen C.-H. He, Anthony K.-C. So, Satyendra C. Tripathi, Manish Kumar, Md. Raghibul Hasan, Jatinder Kaur, Lawrence Kashat, Christina MacMillan, Shyam Singh Chauhan, Jeremy L. Freeman, Paul G. Walfish, Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers PLoS ONE. ,vol. 5, pp. e14130- ,(2010) , 10.1371/JOURNAL.PONE.0014130